Icon
+91 94997 68112
Login Register

DIFLUCAN (nda019949)- (50MG,100MG,150MG,200MG)

FLUCONAZOLE PFIZER
50MG,100MG,150MG,200MG
Yes No
2004-Jul-29 Expired
None None
None No
DIFLUCAN (fluconazole) is indicated for the treatment of: Vaginal candidiasis, Oropharyngeal, Esophageal candidiasis, Cryptococcal meningitis.
9 0 8
Total Other Developers 3
Drugs with Suitability No
50MG ** ** - 6 -
100MG ** ** - 6 -
150MG ** ** - 6 -
200MG ** ** - - 6
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ********* ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***
****** ***** *****-*** *** * * ********* *** *************** ******* *********** **** ********** ******, ****** ** ***-***, *******, ******, ***** (***) ***
****** ******** ****** *** ******** **** ******** ******* *** *********** **** **. ****, **** ********** ******, ******** *******, **********, ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ********* ****** ******** ****** *** *********** **** ***** *** *****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ********* ****** ******** ****** ******* ******* *** *********** ****-**, ****** **. ** & **, ************* ******* ***- *********, ******** ******, **********, ********* ******, ***** (***) ***
****** *** ****** *** ***************, ***. *********** *** *** **** **, ********, ********* (**) *****, ****** ****** (***) ***
****** *** ****** *** *************** ******, ***. *********** *** ******** ***** ****, ********, ** *** ***, ****** (***) ***
****** ***** ****** ***** ************ ******* *********** ******* ****** *****, *.*. *****, ******-********, *****, ******** ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***
****** *** ****** *** ***************, ***. *********** *** **** ****** ****, ********, ********* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.